The percentage of PS-positive circulating cells (as determined by Annexin A5 binding) as well as the number of Annexin A5pos sites per cell as measured ex vivo are increased significantly, e.g., for RVO [11] and sickle cell disease [76,77]. This evidence concerns the gene ANXA5 and sickle cell disease.